X

Clinical Trials Awareness Week: Celebrating the impact of clinical research

Andrew Powaleny   |     May 1, 2017   |   SHARE THIS

Today starts off the beginning of Clinical Trials Awareness Week, which shines a spotlight on how the clinical trials process helps deliver safe, effective medicines to patients.

Each year, hundreds of thousands of clinical trials are ongoing or underway and in the first four months of 2017 alone the number of clinical studies registered has already surpassed the total number registered in 2016, according to Clinicaltrials.gov. These trials are essential to study the benefits and potential risks of new medicines. The U.S. Food and Drug Administration rely on this data to determine whether a new medicine is safe and effective.

Despite the significant breadth and depth of clinical research ongoing in the U.S., many people don’t know the important, life-saving impact these studies have on patients every day. For example, every time you take a medicine – even if it’s just for a headache – you’re benefiting from the knowledge gained from clinical trials.

In addition to patient health, clinical trials are contributing to local economies across the country. The biopharmaceutical industry is responsible for the vast majority of clinical researching, accounting for roughly 90 percent of all spending on clinical trials of medicines and medical devices. In 2013 alone, for example, more than 1 million participants were volunteering in clinical studies across the country.

Industry-funded clinical trials are conducted with careful oversight and are typically in collaboration with a broad range of local institutions, including academic medical research centers, contract research organizations, university medical and pharmacy schools, hospitals, and foundations.

Perhaps no partner is more critical to the R&D process than patients, and our nation’s innovative biopharmaceutical companies are increasingly seeking to incorporate the patient perspective throughout all elements of the R&D process. To those patients who have participated in clinical trials, we say thank you. You have helped spur research and advance science for the betterment of future patients.

We are excited to celebrate Clinical Trials Awareness Week and encourage you to learn more about clinical trials and their impact on patients here.

Andrew Powaleny

Andrew Powaleny is Director of Public Affairs at PhRMA and leads the organizations scientific communications. Before joining PhRMA in 2015, he worked in public affairs for a small firm in Washington, DC and served as Deputy Press Secretary for the House Committee on Energy and Commerce. Andrew came to Washington, D.C. via Connecticut with a degree from Eastern Connecticut State University where he majored in public policy and government. Andrew is active as a runner and volunteer with the DC Front Runners; most recently serving on its Board of Directors for three years as co-race director. He is also a member of the NLGJA: The Association of LGBTQ Journalists and mentors students through his alumni association with The Fund for American Studies. Andrew is passionate about scientific innovation, especially for mental illness, and his heroes are the men and women of America’s biopharmaceutical research companies.

Topics: Clinical Trials

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

see all

Subscribe to Email Updates